PULSE BIOSCIENCES, INC.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
PLSE$55.12-5.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
(a) The following documents are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K:
1.Financial Statements: See Item 8 of this Annual Report on Form 10-K.
2.Financial Statement Schedules: All schedules are omitted because they are not required, are not applicable or the information is included in the consolidated financial statements or notes thereto.
(b) The following exhibits are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K:
| Exhibit · Incorporation by Reference | |||||
|---|---|---|---|---|---|
| Number | Exhibit Description | Form | File No. | Exhibit(s) | Filing Date |
| 2.1 | Plan of Conversion of Pulse Biosciences, Inc. | 8-K12B | 001-37744 | 2.1 | June 18, 2018 |
| 3.1 | Articles of Conversion | 8-K12B | 001-37744 | 3.1 | June 18, 2018 |
| 3.2 | Certificate of Conversion | 8-K12B | 001-37744 | 3.2 | June 18, 2018 |
| 3.3 | Certificate of Incorporation of Pulse Biosciences, Inc. | 8-K12B | 001-37744 | 3.3 | June 18, 2018 |
| 3.4 | Bylaws of Pulse Biosciences, Inc. | 8-K12B | 001-37744 | 3.4 | June 18, 2018 |
| 4.1 | Specimen Common Stock Certificate | 8-K12B | 001-37744 | 4.1 | June 18, 2018 |
| 4.2 | Form of Warrant | S-3 | 333-278494 | 4.3 | April 3, 2024 |
| 4.3 | Form of Warrant Agent Agreement | S-3 | 333-278494 | 4.4 | April 3, 2024 |
| 10.1 | Lease for facilities at 3955 Point Eden Way, Hayward, California, dated January 26, 2017 | 10-K | 001-37744 | 10.1 | March 20, 2017 |
| 10.4+ | Employment Agreement between Mitchell E. Levinson and the Registrant | 10-K | 001-37744 | 10.4 | March 31, 2022 |
| 10.5+ | Employment Agreement between Kevin Danahy and the Registrant | 10-K | 001-37744 | 10.5 | March 31, 2022 |
| 10.6 | Securities Purchase Agreement, dated February 7, 2017, by and between Pulse Biosciences, Inc. and certain purchasers | 8-K | 001-37744 | 10.1 | February 10, 2017 |
| 10.7 | Securities Purchase Agreement, dated September 24, 2017, by and between Pulse Biosciences, Inc. and certain purchasers | 8-K | 001-37744 | 10.1 | September 25, 2017 |
| 10.8+ | 2015 Stock Incentive Plan | S-1 | 333-208694 | 10.2 | December 22, 2015 |
| 10.9+ | 2017 Inducement Equity Incentive Plan and forms of agreements thereunder | 8-K | 001-37744 | 10.1 | November 28, 2017 |
| 10.10+ | 2017 Equity Incentive Plan and forms of agreements thereunder | 10-K | 001-37744 | 10.10 | March 12, 2021 |
| 10.11+ | 2017 Employee Stock Purchase Plan and forms of agreements thereunder | 8-K | 001-37744 | 10.2 | May 19, 2017 |
| 10.13+ | Executive Employment Agreement between Darrin R. Uecker and the Registrant | S-1 | 333-208694 | 10.9 | December 22, 2015 |
| 10.14+ | Amendment to Employment Agreement between Darrin R. Uecker and Pulse Biosciences, Inc. dated October 5, 2016 | 8-K | 001-37744 | 10.1 | October 11, 2016 |
| 10.15+ | Form of At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement for Employees | S-1 | 333-208694 | 10.10 | December 22, 2015 |
| 10.16+ | Form of Indemnification Agreement | 8-K12B | 001-37744 | 10.1 | June 18, 2018 |
| 10.17 | First Amendment to the lease for facilities at 3955 Point Eden Way, Hayward, California, dated May 28, 2019 | 8-K | 001-37744 | 10.19 | May 31, 2019 |
| 10.18 | At-the-Market Equity Offering Sales Agreement | 8-K | 001-37744 | 1.1 | July 15, 2024 |
| 10.19 | Securities Purchase Agreement, dated June 30, 2021, by and between Pulse Biosciences, Inc. and Robert W. Duggan | 8-K | 001-37744 | 10.1 | July 1, 2021 |
| 10.20 | Indemnification Letter, dated May 27, 2022, by and between Pulse Biosciences, Inc. and Robert W. Duggan | 10-Q | 001-37744 | 10.1 | August 10, 2022 |
| 10.21 | Loan Agreement, dated as of September 20, 2022, by and between Pulse Biosciences, Inc. and Robert W. Duggan | 8-K | 001-37744 | 10.1 | September 23, 2022 |
| 10.22+ | Amendment to Employment Agreement, between Darrin Uecker and Pulse Biosciences, Inc., dated September 20, 2022 | 8-K | 001-37744 | 10.2 | September 23, 2022 |
| 10.23+ | Amendment to Employment Agreement, between Kevin Danahy and Pulse Biosciences, Inc., dated September 23, 2022 | 8-K | 001-37744 | 10.1 | September 28, 2022 |
| 10.24+ | Amendment to Employment Agreement, between Kevin Danahy and Pulse Biosciences, Inc., dated May 4, 2023 | 8-K | 001-37744 | 10.1 | May 5, 2023 |
| 10.25+ | Amendment to Employment Agreement, between Darrin Uecker and Pulse Biosciences, Inc., dated May 5, 2023 | 8-K | 001-37744 | 10.2 | May 5, 2023 |
| 10.26+ | Third Amendment to Employment Agreement, between Kevin Danahy and Pulse Biosciences, Inc., dated March 2024 | 10-K | 001-37744 | 10.26 | March 28, 2024 |
| 10.27+ | Fourth Amendment to Employment Agreement, between Darrin Uecker and Pulse Biosciences, Inc., dated March 2024 | 10-K | 001-37744 | 10.27 | March 28, 2024 |
| 10.28+ | Employment Agreement between Paul A. LaViolette and the Registrant | 8-K | 001-37744 | 10.1 | January 13, 2025 |
| 10.29+ | Employment Agreement between Jon Skinner and the Registrant | 8-K | 001-37744 | 10.1 | January 31, 2025 |
| 21.1* | List of Subsidiaries | ||||
| 23.1* | Consent of Independent Registered Public Accounting Firm | ||||
| 31.1* | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2* | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1* | Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350). | ||||
| 32.2* | Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350). | ||||
| 97.1+ | Section 10D Clawback Policy | 10-K | 001-37744 | 97.1 | March 28, 2024 |
| 101.INS | Inline XBRL Instance Document | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||
| * Filed herewith | |||||
|---|---|---|---|---|---|
| + Indicates a management contract or compensatory plan or arrangement. | |||||
| # Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a grant of confidential treatment. | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.